(Q33941657)

30 July 2017

Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference (English)

1 reference

30 July 2017

Bin Tean Teh

14

0 references

William G. Kaelin

6

object named as

William G Kaelin

1 reference

30 July 2017

12

Sabina Signoretti

1 reference

30 July 2017

Michael B Atkins

1

1 reference

30 July 2017

Ronald M Bukowski

2

1 reference

30 July 2017

Bernard J Escudier

3

1 reference

30 July 2017

Robert A Figlin

4

1 reference

30 July 2017

Gary H Hudes

5

1 reference

30 July 2017

W Marston Linehan

7

1 reference

30 July 2017

David F McDermott

8

1 reference

30 July 2017

James W Mier

9

1 reference

30 July 2017

Ivan Pedrosa

10

1 reference

30 July 2017

Brian I Rini

11

1 reference

30 July 2017

Jeffrey A Sosman

13

1 reference

30 July 2017

Christopher G Wood

15

1 reference

30 July 2017

Amado J Zurita

16

1 reference

30 July 2017

Laura King

17

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 May 2009

1 reference

30 July 2017

1 reference

30 July 2017

115

1 reference

30 July 2017

2247-2251

1 reference

30 July 2017

10 Suppl

1 reference

Kinase requirements in human cells: III. Altered kinase requirements in VHL-/- cancer cells detected in a pilot synthetic lethal screen

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2892290

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2892290

Identification of the genes for kidney cancer: opportunity for disease-specific targeted therapeutics

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2892290

Sorafenib in advanced clear-cell renal-cell carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2892290

Sunitinib in patients with metastatic renal cell carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2892290

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2892290

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2892290

Magnetic resonance imaging-measured blood flow change after antiangiogenic therapy with PTK787/ZK 222584 correlates with clinical outcome in metastatic renal cell carcinoma.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2892290

Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma.

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19402064

12 December 2020

inferred from PubMed ID database lookup

Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19402064

12 December 2020

inferred from PubMed ID database lookup

Long-term survival update for high-dose recombinant interleukin-2 in patients with renal cell carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19402064

12 December 2020

inferred from PubMed ID database lookup

Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCNCR.24229

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/CNCR.24229

1 reference

30 July 2017

1 reference

30 July 2017

1 reference